Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/CA/Fresno

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fresno, CA

Studies commonly pay $75 to $4,500 per completed study

168 clinical trials are currently recruiting participants within 30 miles of Fresno. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

168studies recruiting

4+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Fresno right now

Top 25 of 168 recruiting studies, sorted by proximity — each links to its official registry page

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought

Clinical Trial Site — Fresno, California (2.7 mi) · Sponsor: Alexion Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT04202341)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought

Community Cancer Institute ( Site 0100) — Clovis, California (5.8 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06966700)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought

California Cancer Associates for Research & Excellence ( Site 0016) — Fresno, California (2.7 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT03486873)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought

TG Therapeutics Investigational Trial Site — Fresno, California (2.7 mi) · Sponsor: TG Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06433752)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought

Community Cancer Institute (CCI) — Clovis, California (5.8 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06806033)

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought

University of California — Fresno, California (2.7 mi) · Sponsor: W.L.Gore & Associates

See eligibility & contact on ClinicalTrials.gov (NCT06872905)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: PedAL BCU, LLC

See eligibility & contact on ClinicalTrials.gov (NCT04726241)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

Muscular Atrophy, Spinal Phase 4 Interventional 28 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT05861999)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought

89bio Clinical Study Site — Fresno, California (2.7 mi) · Sponsor: 89bio, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06419374)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04322318)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Benign Prostatic Hyperplasia (BPH) N/A Interventional 256 participants sought

Urology Associates of Central California — Fresno, California (2.7 mi) · Sponsor: Olympus Corporation of the Americas

See eligibility & contact on ClinicalTrials.gov (NCT04757116)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought

VA Central California Fresno Medical Center — Fresno, California (2.7 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04871542)

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine Phase 3 Interventional 1,059 participants sought

Neuro Pain Research Center /ID# 227966 — Fresno, California (2.7 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT05125302)

A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

Malocclusion N/A Interventional 90 participants sought

Costanzo Orthodontics — Fresno, California (2.7 mi) · Sponsor: Dentsply Sirona Implants and Consumables

See eligibility & contact on ClinicalTrials.gov (NCT07290790)

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) Phase 3 Interventional 1,800 participants sought

Altimmune Clinical Study Site — Fresno, California (2.7 mi) · Sponsor: Altimmune, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07795164)

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Cardiovascular Disorder, Classic Hodgkin Lymphoma N/A Observational 190 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT05705531)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought

Kaiser Permanente Fresno Orchard Plaza — Fresno, California (2.7 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05987241)

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Wound Heal, Ulcer N/A Interventional 235 participants sought

Limb Preservation Platform — Fresno, California (2.7 mi) · Sponsor: ConvaTec Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06616844)

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome N/A Observational 330 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT05702645)

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 177 participants sought

California Cancer Associates for Research and Excellence — Fresno, California (2.7 mi) · Sponsor: Jazz Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT06108050)

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers N/A Interventional 240 participants sought

Limb Preservation Platform Inc — Fresno, California (2.7 mi) · Sponsor: Tides Medical

See eligibility & contact on ClinicalTrials.gov (NCT06681428)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought

Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought

Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT03150693)

Actively enrolling

Studies you may be able to join near Fresno

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Fresno

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Fresno Clinical Research Center

★ 5.0

7102 N Fresno St Ste 101, Fresno, CA 93720

(559) 712-6199

Website

"Very kind and very professional"

— Vivian, 5★

Beacon Clinical Resarch Institute

1111 E Warner Ave, Fresno, CA 93720

(410) 718-2908

Website

Valley Research

★ 5.0

550 E Herndon Ave #101, Fresno, CA 93720

(559) 261-0992

Website

"I just completed a diabetic study with Valley Research. I worked with Lucas Anderson and Rowena Liwag. The knowledge that was shared was immense, we…"

— Betty Benoit, 5★

Clinical Research Center

Fresno, CA 93720

(559) 450-7790

Website

Clinical trials in Fresno: what's recruiting

The Fresno area currently has 168 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fresno, the most active research areas are:

Cancer & Oncology12 studies
Liver & Kidney4 studies
Diabetes & Metabolism3 studies
Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Fresno, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fresno

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fresno participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fresno pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Fresno?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Fresno safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How often do new paid studies open in Fresno?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fresno.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fresno typically complete one or two studies per year.

Paid clinical trials near Fresno

Other metros within reach

Visalia, CA2 Merced, CA27 Modesto, CA105 Bakersfield, CA68 Salinas, CA46 Stockton, CA106 Santa Maria, CA93 San Jose, CA1,124

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fresno Bladder Issues Due To Spinal Cord Injury in Fresno All conditions

More of CA

Long Beach3,380 Fullerton3,270 Torrance3,259 Anaheim3,214 Garden Grove3,204 Pomona3,172 Glendale2,974 Los Angeles2,951 Huntington Beach2,879 Santa Clarita2,378 Hayward2,267 Oakland2,257

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts